New Breakthrough Study: Modified Citrus Pectin Boosts Chemo’s Power against Ovarian Cancer Ovarian cancer is one of the deadliest cancers because it’s often detected at a late stage, with higher risk of resistance to frontline chemotherapy drugs such as paclitaxel (commonly sold as Taxol). However, a new preclinical study from the University of Tehran and the Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, published in the Asian Pacific Journal of Cancer Prevention showed that Modified Citrus Pectin (MCP) increased the effectiveness of paclitaxel against ovarian cancer cells.
The research on Modified Citrus Pectin (MCP) continues to grow, highlighting its powerful benefits against inflammation and the protein galectin-3 -- a culprit in heart disease, cancer, inflammation and fibrosis. In this powerful new study, published in Arteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, MCP blocked galectin-3 and reduced the inflammation, blood pressure, fibrosis and aortic wall thickness associated with vascular hardening and cardiovascular disease. Furthermore, MCP out-performed the pharmaceutical drug sprironolactone, safely without toxicity. Click here to read more about the study.
American Chemical Society Highlights Modified Citrus Pectin as Solution to Chronic Disease Marker Galectin-3
Cancer, heart disease, chronic inflammation—these disease conditions plague humanity, causing early death and untold suffering. Slowly, scientists are uncovering their numerous causes including genetic anomalies, environmental toxins, obesity and other factors. However, a rapidly expanding body of research points to a single biological culprit that profoundly affects these and other conditions—the molecule Galectin-3.
New Target for Treatment and the Role of MCP – Integrated Healthcare Practitioners Magazine September 2012
Chronic illnesses such as cancer, cardiovascular disease, diabetes and others share common metabolic and inflammatory derangements. Novel epidemiological forecasts predict that a new category of diseases may soon be established, classifying these chronic illnesses as "Elevated Galectin-3 Diseases."
Collection of YouTube videos featuring Dr. Isaac Eliaz, integrative health expert.
Collection of videos featuring Dr. Isaac Eliaz on World News.
Dr. Isaac Eliaz, a pioneer in the field of integrative medicine since the early 1980s, is a respected author, lecturer, researcher, product formulator and clinical practitioner. Since 1991, Dr. Eliaz has maintained a busy private practice in northern California that focuses primarily on integrative, holistic protocols for cancer patients. He leads an integrative medical team at Amitabha Clinic in Sebastopol, California with focus on cancer and other chronic ailments.
There’s still no cure for cancer. But new research looks promising. Because of its unique molecular structure, Modified Citrus Pectin, or MCP (of the correct molecular weight and size), can easily enter the bloodstream and work throughout the body to fight cancer and address numerous other serious diseases and health concerns. For example, MCP is a powerful yet gentle natural chelator, proven to bind to and remove harmful heavy metals and environmental toxins from the body without affecting essential minerals, as many chelation therapies do. MCP is also a powerful immune modulator, proven to boost immune cells and strengthen immune function. First, let me explain a little bit about a molecule within the body called Galectin-3 (normally present in small amounts in healthy people). Groundbreaking new studies show that excess galectin-3 molecules have a direct involvement in the process of chronic inflammation and subsequent fibrosis (uncontrolled scar tissue build up). Research shows that elevated levels of galectin-3 molecules in the body promote the growth and spread of cancer. Here’s where MCP comes in: it is the only proven natural galectin-3 “blocker,” proven to bind to and block harmful galectin-3 molecules on the surface of cancer cells. This prevents them from growing, creating new blood supplies to nourish themselves (a process called angiogenesis) and metastasizing.
Cancer is an insidious disease that often finds ways to defeat the most advanced treatments. As a result, the scientific and medical communities have become increasingly aware that a multi-pronged approach is the best way to beat cancer. On June 16-17, at the Second International Congress on Complementary Oncology in Munich, Germany, integrative medicine pioneer Isaac Eliaz, MD joined leading experts in the field of complementary oncology. During his visit, he shared research advancements demonstrating how integrative therapies can boost our abilities against cancer. "It was a privilege to speak to such a receptive audience at the Germany International Congress on Complementary Oncology. This conference provides a wonderful opportunity to share important information on integrative treatments and learn about new strategies to defeat cancer," says Dr. Eliaz. "Having the opportunity to give two separate presentations on each day of the congress allowed me to cover a wider array of important topics."
The prostate is an odd, walnut-sized organ at the base of the pelvis below the bladder. When functioning properly, most men don't even know it's there. On the other hand, men with a prostate issue think of little else. Conditions like prostate cancer, benign prostate hyperplasia (BPH) and prostatitis can cause pain and discomfort, and dramatically reduce quality of life.